Skip to content
+1 (800) 559-9921
MRM Proteomics
  • Shop
    • Kits
      • MetaboloMetrics™ Kits
      • PeptiQuant™ Plus Kits
        • Human Plasma
        • Mouse Plasma
        • Quality Control
    • Request a Quote
  • About Us
    • Company
    • Technology
  • Services
    • Service Portfolio
    • Clinical Diagnostics
    • Metabolomics
    • PeptiQuant™ Protein Quantitation
    • Protein Characterization
    • Tissue Imaging
  • Products
    • MetaboloMetrics™ Kits
      • Amino Acids
      • Bile Acids
    • PeptiQuant™ Plus Kits
      • Protein Quantitation
      • Quality Control
    • PeptiCov
  • Workshops
  • News
    • News
    • Events
    • Publications
  • Contact

Targeted proteomics for evaluating risk of venous thrombosis following traumatic lower-leg injury or knee arthroscopy

Share:

Facebook
Twitter
Google+
LinkedIn
Pinterest

Post navigation

Previous PostMultiple reaction monitoring-mass spectrometry enables robust quantitation of plasma proteins regardless of whole blood processing delays that may occur in the clinic
Next PostA protocol for identifying the binding sites of small molecules on the cystic fibrosis transmembrane conductance regulator (CFTR) protein
sophiab

Written by Sophia Borchers

What are you looking for?

MRM Proteomics Inc. was established in 2010 as a spin-out company to commercialize the cutting-edge proteomics technologies, tools and know-how developed at the University of Victoria-Genome BC Proteomics Centre.

CONTACT

MRM Proteomics Inc.
SB-5100
141, Ave du Président-Kennedy
Montreal, QC, H2X 1Y4 Canada

Tel: +1 (800) 559-9921
Email: info@mrmproteomics.com
URL: www.mrmproteomics.com

QUICK LINKS

Company Technology Services Products News Contact

GENERAL

Terms and Conditions Shipping FAQ Privacy Policy Terms of Use Resources Calendar of Events
2019 © MRM Proteomics. All Rights Reserved | Privacy Policy